Hyphens Pharma Philippines, Inc.
distributorDescription
Hyphens Pharma focuses on the sales and marketing of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States. Established presence in the region ASEAN is a growing market with more than 600 million people. With a rising middle-income group, it is the third-most populous region in the world, after South Asia and East Asia. According to a 2018 White Paper by Solidance, the total healthcare spending for six major ASEAN economies – Singapore, Malaysia, Vietnam, Indonesia, the Philippines and Thailand – is forecasted to rise to USD 740 billion (2025) from USD 420 billion (2017). The demand for quality healthcare products will grow in tandem. With our competent sales and marketing teams and strong in-house regulatory capabilities, Hyphens Pharma is well-positioned to capture this growth opportunity. We operate directly in Singapore (HQ), Malaysia, Vietnam, Indonesia and the Philippines.
Address
Our Address:
2Nd Floor, Unit 3 Gfo Bldg., 122 Kamuning Rd, Kamuning, Quezon City
Email address:
---
Island:
Luzon
Site:
Kamuning
Province:
Metro Manila
Province PSGC:
137500000
Region Name:
National Capital Region
Region PSGC:
---
Municipality Name:
Quezon City
Municipality PSGC:
137404000
Country:
Philippines
Postcode:
1126
Phone number:
(02) 8706 3386
Contact Person:
---
Contact Title:
---
Contact2:
---
Contact2 Title:
---
Barangay Name:
---
Barangay PSGC:
---
Health Facility Code:
---
Health Facility Code Short:
---
Ownership Major Classification:
Hyphens Pharma Philippines, Inc.
Ownership Sub Classification for Government Facilities:
---
Description
Hyphens Pharma focuses on the sales and marketing of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States. Established presence in the region ASEAN is a growing market with more than 600 million people. With a rising middle-income group, it is the third-most populous region in the world, after South Asia and East Asia. According to a 2018 White Paper by Solidance, the total healthcare spending for six major ASEAN economies – Singapore, Malaysia, Vietnam, Indonesia, the Philippines and Thailand – is forecasted to rise to USD 740 billion (2025) from USD 420 billion (2017). The demand for quality healthcare products will grow in tandem. With our competent sales and marketing teams and strong in-house regulatory capabilities, Hyphens Pharma is well-positioned to capture this growth opportunity. We operate directly in Singapore (HQ), Malaysia, Vietnam, Indonesia and the Philippines.